Blackstone (BX) and TPG (TPG) are taking women’s health leader Hologic Inc. (HOLX) private in one of the largest healthcare buyouts of 2025, valuing the Massachusetts-based company at up to $18.3 billion including debt. The all-cash deal, announced Tuesday, will pay Hologic…
Wall Street’s radar has lit up Monday as a collection of standout corporate and commodity stories shaped the trading landscape, not to mention the shift in understanding with regard to the Whte House's ongoing negation with China and tariffs—from consumer brands clawing…
Rani Therapeutics Holdings (NASDAQ: RANI) has unveiled a transformative partnership with Japan’s Chugai Pharmaceutical Co. valued at up to $1.085 billion, coupled with a $60.3 million private placement that strengthens its capital position through 2028.
The Chugai Collaboration
Under the agreement, Chugai will make…
A Discovery That Redefined Immunity
The 2025 Nobel Prize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for breakthroughs that revealed how the immune system prevents itself from turning on the body—a discovery that…
Praxis Precision Medicines’ (PRAX) stock erupted Thursday up greater than 200% currently after the company reported decisive Phase 3 results for its essential tremor drug, sending shares to an all-time high and erasing months of skepticism.
Breakthrough Data Revives a Struggling Program…
InterGroup Corporation (INTG) recently reported marked financial improvement for the fiscal year ended June 30, 2025, with strengthened core business results and a substantial rebound in its liquidity position, while returning to compliance with Nasdaq listing requirements.
Stock Performance Overview
Over the…
Novo Nordisk (NVO, $56.70, +.05%) and Omeros Corporation (OMER $10.52, +157%) unveiled a sweeping asset purchase and license agreement Wednesday, catapulting the Danish diabetes powerhouse deeper into rare disease territory with a potential $2.1 billion pact for Omeros’ experimental MASP-3 inhibitor, zaltenibart.…
Tribe Public’s latest CEO Presentation and Q&A brought the spotlight to Eupraxia Pharmaceuticals Inc. (Nasdaq: EPRX), a clinical-stage biotech whose innovations in drug delivery have market watchers turning their heads. On October 14, investors got direct access to Chief Executive Officer James…
Nokia (NOK) has further solidified its role as a central driver of digital transformation in Africa and Europe by extending its strategic partnership with Vodafone and Vodacom, marking a significant leap forward in next-generation connectivity and sustainable infrastructure enhancement.
Partnership Scope and…
Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company based in Santa Clara, California, has been selected by the U.S. Department of Energy (DOE) for a pivotal initiative to pilot advanced nuclear fuel line projects. This selection, conducted under the Gateway for…
